The name Gossamer Bio depicts the symbolism behind the gossamer thread, the invisible and fragile connection that binds all relationships in life. In our context, this is intended to highlight the importance of our relationships with our employees, shareholders, providers, partners and patients in a healthcare system. We take these relationships seriously and aim to continuously strengthen these connections. Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Our goal is to create a business that allows value creation and capture at the individual asset level, long-term sustainability, and continuity, while ultimately helping to improve the lives of patients.

Faheem Hasnain
Co-Founder, Chairman, and Chief Executive Officer

Richard Aranda, M.D.
Chief Medical Officer

Jeff Boerneke
General Counsel and Secretary

Laura Carter, Ph.D.
Chief Scientific Officer

Matt Cravets
Senior Vice President, Biometrics

Bryan Giraudo
Chief Operating Officer & Chief Financial Officer

Lisa Nolan, Ph.D.
Managing Director and President, Gossamer Bio Ireland

Mario Orlando
Senior Vice President, Commercial New Product Planning

Caryn Peterson
Executive Vice President, Regulatory Affairs

Colin Rowlings, Ph.D.
Senior Vice President, CMC

Christian Waage
Executive Vice President, Technical Operations & Administration

Deanna Weber
Senior Vice President, Human Resources